FDA.reportPublic FDA data

10 ML margetuximab-cmkb 25 MG/ML Injection

RxCUI
2474028
RxNorm name
10 ML margetuximab-cmkb 25 MG/ML Injection
Display name
10 ML margetuximab-cmkb 25 MG/ML Injection
Full name
10 ML margetuximab-cmkb 25 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761150Margenzamargetuximab-cmkb351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MARGENZAMARGETUXIMAB-CMKBTerSera Therapeutics LLC6a6d50c7-06ea-479c-83cc-f197a9e428c92025-02-11Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2474028
MARGENZAMARGETUXIMAB-CMKBMacroGenics, Ince97a5872-eabf-463b-8f4c-5b5aed9c7bf02025-01-23Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2474028

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
e97a5872-eabf-463b-8f4c-5b5aed9c7bf010 ML margetuximab-cmkb 25 MG/ML InjectionSCD6These highlights do not include all the information needed to use MARGENZA safely and effectively. See full prescribing information for MARGENZA. MARGENZA ® (margetuximab-cmkb) injection, for intravenous use Initial U.S. Approval: 202020250123
e97a5872-eabf-463b-8f4c-5b5aed9c7bf0margetuximab-cmkb 250 MG per 10 ML InjectionSY6These highlights do not include all the information needed to use MARGENZA safely and effectively. See full prescribing information for MARGENZA. MARGENZA ® (margetuximab-cmkb) injection, for intravenous use Initial U.S. Approval: 202020250123
e97a5872-eabf-463b-8f4c-5b5aed9c7bf0margetuximab-cmkb 250 MG in 10 ML InjectionPSN6These highlights do not include all the information needed to use MARGENZA safely and effectively. See full prescribing information for MARGENZA. MARGENZA ® (margetuximab-cmkb) injection, for intravenous use Initial U.S. Approval: 202020250123
6a6d50c7-06ea-479c-83cc-f197a9e428c9margetuximab-cmkb 250 MG in 10 ML InjectionPSN1These highlights do not include all the information needed to use MARGENZA safely and effectively. See full prescribing information for MARGENZA. MARGENZA ® (margetuximab-cmkb) injection, for intravenous use Initial U.S. Approval: 202020250211
6a6d50c7-06ea-479c-83cc-f197a9e428c910 ML margetuximab-cmkb 25 MG/ML InjectionSCD1These highlights do not include all the information needed to use MARGENZA safely and effectively. See full prescribing information for MARGENZA. MARGENZA ® (margetuximab-cmkb) injection, for intravenous use Initial U.S. Approval: 202020250211
6a6d50c7-06ea-479c-83cc-f197a9e428c9margetuximab-cmkb 250 MG per 10 ML InjectionSY1These highlights do not include all the information needed to use MARGENZA safely and effectively. See full prescribing information for MARGENZA. MARGENZA ® (margetuximab-cmkb) injection, for intravenous use Initial U.S. Approval: 202020250211